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Human lactoferrin (hLf), an 80-kDa multifunctional iron-binding cationic glycoprotein, is 
constitutively secreted by exocrine glands and by neutrophils during inflammation. hLf 
is recognized as a key element in the host immune defense system. The in vitro and 
in  vivo experiments are carried out with bovine Lf (bLf), which shares high sequence 
homology and identical functions with hLf, including anti-inflammatory activity. Here, in 
“pure” M1 human macrophages, obtained by stimulation with a mixture of 10 pg/ml 
LPS and 20 ng/ml IFN-γ, as well as in a more heterogeneous macrophage population, 
challenged with high-dose of LPS (1 µg/ml), the effect of bLf on the expression of the 
main proteins involved in iron and inflammatory homeostasis, namely ferroportin (Fpn), 
membrane-bound ceruloplasmin (Cp), cytosolic ferritin (Ftn), transferrin receptor 1, and 
cytokines has been investigated. The increase of IL-6 and IL-1β cytokines, following 
the inflammatory treatments, is associated with both upregulation of cytosolic Ftn and 
downregulation of Fpn, membrane-bound Cp, and transferrin receptor 1. All these 
changes take part into intracellular iron overload, a very unsafe condition leading in vivo to 
higher host susceptibility to infections as well as iron deficiency in the blood and anemia 
of inflammation. It is, therefore, of utmost importance to counteract the persistence of 
the inflammatory status to rebalance iron levels between tissues/secretions and blood. 
Moreover, levels of the antiinflammatory cytokine IL-10 were increased in cells treated 
with high doses of LPS. Conversely, IL-10 decreased when the LPS/IFN-γ mix was used, 
suggesting that only the inflammation triggered by LPS high doses can switch on an 
anti-inflammatory response in our macrophagic model. Here, we demonstrate that bLf, 
when included in the culture medium, significantly reduced IL-6 and IL-1β production 
and efficiently prevented the changes of Fpn, membrane-bound Cp, cytosolic Ftn, and 
transferrin receptor 1 in “pure” M1 macrophages, as well as in the more heterogeneous 
macrophage population. In addition, the decrease of IL-10 induced by the LPS/IFN-γ 
mix was counteracted by bovine lactoferrin. Several drugs capable of modulating mac-
rophagic phenotypes are emerging as attractive molecules for treating inflammation, and 
in this sense, bovine lactoferrin is no exception.
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inTrODUcTiOn
Iron is essential for living organisms, being required in many 
proteins for a broad range of vital functions, such as oxygen trans-
port and energy production. However, it can be toxic when in 
excess due to its ability to partially reduce oxygen, thus generating 
reactive oxygen species, which are known to cause tissue injury 
and organ failure by damaging a number of cellular components, 
including DNA, proteins, and membrane lipids. This has led to 
the evolution of strictly controlled pathways of iron uptake and 
release to minimize its deficiency or excess (1).
Systemic iron homeostasis is tightly controlled in humans. 
Both iron acquisition by enterocytes and iron recycling by 
macrophages are regulated through iron absorption, storage, and 
export, as mammals lack a direct iron excretion system (2, 3). In 
physiological conditions, enterocytes absorb 1–2 mg/day of iron, 
while macrophages recycle about 20 mg/day of iron from senes-
cent erythrocytes. Consequently, recycled iron is the larger source 
of iron in the plasma compared to that exported by enterocytes 
and hepatocytes.
Dietary iron enters the body at the duodenal level through 
the concerted action of the ferrireductase DCYTB and the metal 
importer DMT-1 (4). Enterocytes then pour iron in the plasma 
through ferroportin (Fpn), the only iron exporter identified in 
mammalian cells, situated on the basolateral membrane of the 
enterocytes but also present in all other cell types involved in iron 
export, including hepatocytes, macrophages, and placental syn-
cytiotrophoblasts (5, 6). Another controller of iron homeostasis 
is hepcidin, a peptide hormone synthesized by hepatocytes (7) 
that induces the degradation of Fpn, thus hindering iron export 
and causing intracellular iron overload (1). On the other hand, a 
positive regulation of Fpn is exerted by a companion ferroxidase 
that not only has been shown to stabilize Fpn on the plasma 
membrane (8) but is also pivotal to convert the exported ferrous 
iron into its ferric form to allow its binding to serum transferrin 
(9). In mammals, two homologous ferroxidases exert this role: 
hephestin, mainly expressed by small intestine, spleen and kidney 
cells, and ceruloplasmin (Cp), which is synthesized by hepato-
cytes, macrophages, and immune cells (9). In turn, two isoforms 
of Cp are found: soluble Cp is mainly found in plasma, while 
the glycosyl-phosphatidyl-inositol-anchored form (Cp-GPI) has 
been identified in numerous tissues in addition to macrophages 
and immune cells (9). Once in the portal circulation, ferric iron 
chelated by transferrin is transported to sites of use and stor-
age and released through receptor-mediated endocytosis (10). 
Uptaken iron is either promptly utilized by the cell or stored 
into cytosolic ferritin (Ftn), a protein composed of 24 subunits 
endowed with ferroxidase activity, able to harbor up to 4,500 iron 
atoms per molecule as oxy-hydroxide micelles (11).
During infection and inflammation, iron homeostasis is 
grossly perturbed, leading to iron disorders. Enterocytes and 
macrophages become iron overloaded, thus increasing the host 
susceptibility to infections (12). On the other hand, the intracel-
lular iron overload is associated to the decrease of Fpn synthesis, 
leading to diminished transport of iron into plasma with conse-
quent iron deficiency anemia (IDA) and anemia of inflammation 
(AI) (12, 13). The cytokine-induced “anemia of inflammation” 
has been primarily considered as a defense mechanism to limit 
iron availability to pathogens in the blood (14, 15). However, in 
light of the ability of bacteria to enter and survive inside mac-
rophages, this concept should be critically reconsidered. In fact, 
intracellular iron retention could be an inducer of intracellular 
pathogens’ growth and lead to increased infection severity. It is, 
therefore, of utmost importance to counteract the persistence of 
the inflammatory status to rebalance iron levels between tissues/
secretions and blood.
In this respect, specific cells express molecules that sequester 
iron to promote host defense. In particular, many mucosal epi-
thelia secrete human lactoferrin (hLf), an 80-kDa iron-binding 
cationic glycoprotein, which, at variance with transferrin, is able 
to chelate two Fe (III) per molecule with high affinity even at the 
very low pH values, characteristic of inflamed and infected sites 
(16). It is also secreted and released by neutrophils during inflam-
mation. hLf is recognized as a key element in the host immune 
defense system (17).
In addition to the antimicrobial properties dependent and 
independent from its iron-binding ability, hLf exhibits a variety 
of effects on the host immune system, ranging from inhibition of 
inflammation to promotion of both innate and adaptive immune 
responses (17, 18).
Bovine Lf (bLf), which shares high sequence homology with 
the human protein, is also a multifunctional glycoprotein with 
identical antibacterial, antifungal, antiviral, antiparasitic (18), 
anti-inflammatory, and immunomodulatory activities of hLf 
(19, 20). The majority of the in vitro studies as well as clinical trials 
have been carried out using bLf, generally recognized as a safe 
substance by Food and Drug Administration (USA) and available 
in large quantities.
Evidence indicates that bLf modulates inflammation by 
affecting expression of cytokines, chemokines, and other effector 
molecules. For instance, oral administration of bLf modulates the 
expression of IL-6, the main cytokine involved in inflammatory 
and iron homeostasis, reverting homeostasis disorders in preg-
nant women suffering from IDA and AI (21–23).
Previously, we demonstrated that bLf affects iron homeostasis 
in inflamed models of both epithelial and macrophagic cells by 
inhibiting IL-6 production and rescuing the expression of the 
iron exporter Fpn (24, 25).
Although the mechanisms underlying bLf anti-inflammatory 
properties have not been fully elucidated yet, its interaction with 
macrophages may play a critical role.
In this work, we have extended our study, investigating 
the effect of bLf on the expression of all pivotal proteins (Fpn, 
membrane-bound Cp, cytosolic Ftn, transferrin receptor 1, 
and cytokines) involved in mammalian iron and inflammatory 
homeostasis in a model of inflamed human macrophagic THP-1 
cells, challenged with a mixture of LPS and IFN-γ or with LPS 
alone. The rationale is that macrophages can adapt their pheno-
type in response to different environmental stimuli and that the 
iron system proteins are expressed at different extent in different 
macrophagic phenotypes. Here, we reported the effect of bLf 
added both to a classical mixture of low concentrations of LPS 
and IFN-γ, known to induce a pure M1 polarization, and to high 
concentrations of LPS, known to induce a mixed inflammatory 
FigUre 1 | Increase of IL-6 levels in THP-1 cells, differentiated in 
macrophages by phorbol myristate acetate treatment, cultured for different 
times. T15–T60 refer to days after the cell batch had been thawed.
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M1/tolerogenic M2 phenotypic population on the expression of 
iron and inflammatory homeostasis.
MaTerials anD MeThODs
lactoferrin
Highly purified bLf was kindly provided by Morinaga Milk 
Industries Co., Ltd. (Tokyo, Japan). The purity of bLf was checked 
by SDS-PAGE and silver nitrate staining, while its concentration 
was assessed by UV spectroscopy on the basis of an extinction 
coefficient of 15.1 (280 nm, 1% solution). The bLf iron saturation 
was about 20% as detected by optical spectroscopy at 468 nm on 
the basis of an extinction coefficient of 0.54 (100% iron saturation, 
1% solution). LPS contamination of bLf, estimated by Limulus 
Amebocyte assay (Pyrochrome kit, PBI International), was equal to 
0.7 ± 0.06 ng/mg of bLf. Before biological assays, bLf solution was 
sterilized by filtration using 0.2 µm Millex HV at low protein reten-
tion (Millipore Corp., Bedford, Mass.). In all experiments, bLf was 
used at a non-cytotoxic concentration corresponding to 100 µg/ml.
cell line and culture condition
THP-1 cells, a myelomonocytic cell line derived from the blood 
of a 1-year-old boy with acute monocytic leukemia (ECACC, 
European Collection of Cell Cultures), were maintained in RPMI 
1640 medium (Euroclone, Italy), supplemented with 10% fetal 
calf serum and 2  mM glutamine, in an atmosphere of 95% air 
and 5% CO2. Cells, which grow spontaneously in loose suspen-
sion under these conditions, were subcultured twice a week by 
gentle shaking followed by pelleting and reseeding at a density of 
approximately 106 cells/ml.
stimulation of Differentiated ThP-1  
with lPs and iFn-γ
THP-1 cells were differentiated in macrophages by incubation in 
25 cm2 flasks at a density of approximately 106 cells/ml in 5 ml 
of RPMI (supplemented with 100  µM penicillin–streptomycin, 
2  mM glutamine, 10% fetal calf serum) containing 0.16  µM 
phorbol myristate acetate (PMA, Sigma Chemical Co.) for 
48  h, at 37°C in an atmosphere of 95% air and 5% CO2 (26). 
Differentiated THP-1 cells were washed twice with 5 ml of PBS 
without calcium and magnesium and treated with 10 pg/ml LPS 
from E. coli (InvivoGen, USA) and 20 ng/ml IFN-γ (Sigma, Italy), 
or with 1 µg/ml LPS. The stimulations were carried out for 48 h 
in an atmosphere of 95% air and 5% CO2, at 37°C. 100  µg/ml 
bLf were added to adherent THP-1 cells, without removing the 
culture medium, after 3 and 24 h from the stimulation. After 48 h 
of incubation, the supernatants were harvested, aliquoted, and 
stored at −80°C for cytokines quantitation. The adherent cells 
were scraped in 2 ml of PBS containing 1 mM phenylmethylsul-
fonyl fluoride (PMSF), pelleted by centrifugation at 2,500 × g for 
5 min, and stored at −80°C for protein analysis.
cytokine analysis
Quantitation of IL-6, IL-1β, and IL-10 was performed on cell 
monolayer supernatants by ELISA, using Human ELISA Max 
Deluxe Sets (BioLegend, USA).
Western Blots
THP-1 cells (about 5 × 106 cells) were lysed in 300 µl of lysis buffer 
(25 mM 3-morpholinopropane-1-sulfonic acid pH 7.4/150 mM 
NaCl/1% Triton containing 1  mM PMSF, 2  µM leupeptin, and 
pepstatin) in ice for 1  h. Total protein content of samples was 
measured by Bradford assay. For SDS-PAGE, 20  µg of total 
protein in SDS sample buffer containing 1,4-dithiothreitol, 
were heat-treated (except for Fpn) and loaded. For Western Blot 
analysis, primary antibodies used were: monoclonal anti-Fpn 
31A5, generously provided by T. Arvedson (Amgen) (1:10,000) 
(27), monoclonal anti-transferrin receptor 1 (anti-TfR) (Santa 
Cruz, CA, USA) (1:5,000), polyclonal anti-Ftn (Santa Cruz, CA, 
USA) (1:10,000), monoclonal anti-actin (Santa Cruz, CA, USA) 
(1:10,000), and polyclonal anti-HCP (Dako, USA) (1:10,000). 
After incubation with the appropriate secondary Horseradish 
Peroxidase-conjugated antibody, blots were developed with 
Enhanced ChemiLuminescence (ECL Prime) (GE Healthcare, 
UK). Protein levels were normalized on actin by densitometry 
analysis, performed with ImageJ.
statistical analysis
All experiments were run at least in triplicate. Results are expressed 
as mean ± SE. Statistical analysis was performed with GraphPad 
Prism and analysis of variance was used to compare quantitative 
data populations with normal distribution and equal variance.
resUlTs
ThP-1 and inflammation: aging effect  
on il-6 Production
Preliminary experiments showed that THP-1 cells are usually 
very prone to rapid aging. As shown in Figure 1, THP-1 cells, 
differentiated in macrophages by PMA treatment, show an 
exponential increase of IL-6 production, starting from the T15, 
corresponding to day 15 from thawing, to T60. This sort of 
auto-inflammation process results in non-reproducible response 
to stimuli during cell aging. For this reason, for all experiments 
shown in this work, we used cells before T20.
FigUre 2 | Changes in IL-6 (a), IL-1β (B), ferroportin (c), membrane-bound ceruloplasmin (D), transferrin receptor 1 (e), and cytosolic ferritin (F) levels in THP-1 
cells stimulated with a mixture of 20 ng/ml IFN-γ and 10 pg/ml LPS, in the presence or absence of 100 μg/ml bLf. #p < 0.05; *p < 0.01; &p < 0.001.
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Bovine lactoferrin counteracts the ThP-1 
inflammatory Phenotype induced by lPs 
and iFn-γ
To induce the inflammatory macrophagic phenotype M1, 
cells were stimulated with 10 pg/ml LPS and 20 ng/ml IFN-γ, 
alone or in combination, in the presence or absence of 100 µg/
ml bLf.
As shown in Figures 2A,B, levels of both pro-inflammatory 
cytokines analyzed, IL-6 and IL-1β, significantly increased upon 
treatment with the mixture, with bLf counteracting the increase 
by ca. 30 and 40%, respectively. Of note, no significant effects 
on IL-6 and IL-1β synthesis were observed in samples stimulated 
with LPS or IFN-γ alone, as well as for bLf on unstimulated cells.
Ferroportin and Cp-GPI synthesis followed the same pattern, 
with expression of both proteins severely impaired when cells were 
FigUre 3 | Changes in IL-10 levels in THP-1 cells stimulated with  
(a) a mixture of 20 ng/ml IFN-γ and 10 pg/ml LPS or (B) LPS 1 µg/ml in the 
presence or absence of 100 µg/ml bovine Lf (bLf) (#p < 0.05; *p < 0.01; 
&p < 0.001).
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challenged with the mixture of LPS and IFN-γ (Figures 2C,D). In 
the case of Fpn, single treatments (i.e., LPS or IFN-γ alone) were 
less effective in downregulating the protein production, with LPS 
being more effective than IFN-γ (Figure 2C). On the other hand, 
single treatments downregulated Cp-GPI synthesis as efficiently 
as the LPS/IFN-γ mix (Figure 2D). bLf significantly rescued the 
expression of both proteins in cells stimulated with both LPS and 
IFN-γ. In the case of Cp-GPI, the recovery was not significant 
when related to single treatments (p values higher than 0.05). The 
concerted regulation of Fpn and Cp-GPI is consistent with the 
known functional connection between the two proteins (9).
Expression of TfR1 and Ftn was also found to change, and 
again production of the relative proteins was significantly affected 
only by the combined treatment with both LPS and IFN-γ, while 
being essentially unchanged after single stimulatory treatments. 
However, TfR1 expression was ca. 40% downregulated by the 
mixture (Figure  2E), while Ftn production increased about 
twofold upon stimulation with LPS and IFN-γ (Figure  2F). In 
any case, the presence of bLf totally prevented the effects of the 
pro-inflammatory mixture.
When IL-10 was measured as a marker of the tolerogenic, 
anti-inflammatory status of macrophages, it turned out that the 
treatment with the LPS/IFN-γ mixture dramatically reduced the 
cytokine levels (Figure 3A). Again, when cells were stimulated 
in the presence of bLf, this IL-10 decrease was almost completely 
abolished, suggesting that bLf effectively acts as an anti-inflam-
matory molecule under these conditions.
Bovine lactoferrin reduces inflammation 
and rebalances iron homeostasis in 
ThP-1 cells challenged with 1 µg/ml lPs
In order to assess whether the observed effects were confined to 
pro-inflammatory macrophages induced by the LPS/IFN-γ mix-
ture, we treated differentiated THP-1 with high concentrations 
of LPS alone. Under these conditions, macrophages likely evolve 
into a heterogeneous population with phenotypes ranging from 
pro-inflammatory M1 to tolerogenic M2 (28). THP-1 cells were, 
therefore, stimulated with 1 µg/ml LPS, a concentration mimick-
ing an infection from Gram-negative bacteria, in the presence or 
absence of 100 µg/ml bLf, and production of IL-6 and IL-1β as 
well as expression of Fpn, TfR1, Ftn, and Cp-GPI was assessed. 
As already observed with the IFN-γ/LPS mixture, a significant 
increase of IL-6, IL-1β, and Ftn and a parallel decrease of TfR1, 
Cp-GPI, and Fpn occurred upon LPS stimulation, all these effects 
being significantly prevented in the presence of bLf (Figure 4).
As with the stimulation with the LPS/IFN-γ mixture, no effect 
on IL-6, IL-1β, Fpn, TfR1, Ftn, and Cp-GPI production was 
detected in the control cells treated with bLf alone.
The changes of IL-10 observed upon stimulation with 1 µg/
ml LPS were at odd with those observed with the LPS/IFN-γ 
mixture. As shown in Figure 3, while the inflammatory mixture 
grossly quenched IL-10 production (Figure  3A), LPS alone at 
1 µg/ml concentration enhanced instead the cytokine synthesis 
more than 10-fold (Figure 3B). bLf had in this case the opposite 
effect, rebalancing the IL-10 levels toward lower values (yet much 
higher than in control, untreated cells).
Representative Western Blot assays on Fpn, TfR1, Ftn, and 
Cp-GPI in THP-1 cells stimulated both with a mixture of 20   
ng/ml IFN-γ and 10 pg/ml LPS or with LPS 1 µg/ml, in the pres-
ence or absence of 100 µg/ml bLf are shown in Figure 5.
DiscUssiOn
Microorganisms require iron for the biosynthesis of macromol-
ecules, thus pathogens have developed efficient systems to take up 
iron from the host. In turn, hosts rely on innate immune strategies 
that limit iron availability by finely regulating host genes involved 
in iron homeostasis. In this respect, it is of utmost importance 
to analyze how macrophages, which are crucial cellular types of 
the innate immune system, respond to inflammatory stimuli. 
Our data clearly show that a whole set of proteins involved in 
iron homeostasis is coordinately regulated upon stimulation of 
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FigUre 4 | Changes in IL-6 (a), IL-1β (B), ferroportin (c), membrane-bound ceruloplasmin (D), transferrin receptor 1 (e), and cytosolic ferritin (F) levels in THP-1 
cells stimulated with LPS 1 μg/ml, in the presence or absence of 100 μg/ml bLf. #p < 0.05; *p < 0.01; &p < 0.001.
macrophages with inflammatory triggers. These changes take 
part into intracellular iron overload, a very unsafe condition 
in vivo, leading to higher host susceptibility to infections as well 
as to the IDA or AI.
Here, we clearly demonstrate that the anti-inflammatory 
effect of bovine lactoferrin is exerted on all examined compo-
nents of the iron homeostasis machinery. It should be reminded 
that macrophages are a heterogeneous population of immune 
cells resulting from cytokine stimulation and pathogen or its 
products sensing. Indeed, depending on the microenvironment, 
macrophages are able to polarize into active subpopulations, 
with a continuum of macrophage subsets ranging from pro- 
inflammatory M1 to regulatory/anti-inflammatory M2 pheno-
types. Stimulation of macrophages with low-dose LPS and IFN-γ 
leads to classical pro-inflammatory M1 polarization, while the 
widely used high-dose LPS stimulus gives rise to a more het-
erogeneous phenotype (28). It has been reported that, depending 
on M1 or M2 polarization, macrophages express at different 
7Cutone et al. Lactoferrin Modulates Iron Homeostasis in Macrophages
Frontiers in Immunology | www.frontiersin.org June 2017 | Volume 8 | Article 705
FigUre 5 | Representative Western Blot assays on ferroportin (Fpn), membrane-bound ceruloplasmin (Cp), transferrin receptor 1, and cytosolic ferritin (Ftn) in 
THP-1 cells stimulated both with a mixture of 20 ng/ml IFN-γ and 10 pg/ml LPS or with LPS 1 µg/ml, in the presence or absence of 100 µg/ml bovine Lf (bLf).
extent a set of genes related to iron homeostasis leading to an 
“iron-retention” or an “iron-release” phenotype, respectively 
(29, 30). Thus, the cellular iron homeostasis machinery appears 
to be tightly regulated by inflammatory stimuli, with different 
outcomes depending on macrophage phenotype.
In this work, we demonstrate that bovine lactoferrin affects 
the expression of Fpn, TfR1, Ftn, and Cp-GPI in “pure” M1 mac-
rophages obtained by stimulation with low-dose LPS and IFN-γ 
as well as in a more heterogeneous macrophage population, chal-
lenged with high-dose LPS.
In line with the expected “iron-retention” phenotype, levels 
of Ftn are increased while TfR1, Fpn, and Cp-GPI are decreased 
in M1 macrophages (low-dose LPS and IFN-γ). We demonstrate 
that bovine lactoferrin efficiently counteracts the effect of LPS 
and IFN-γ, restoring Fpn, Cp-GPI, Ftn, and TfR1 levels to 
those of unstimulated, uninflamed cells. The decrease of the 
anti-inflammatory cytokine IL-10 induced by low-dose LPS and 
IFN-γ is also counteracted by bovine lactoferrin.
Also in the case of stimulation with high-dose LPS, the phe-
notype appears to be one of “iron-retention” with higher levels 
of Ftn and lower expression of iron uptake/export proteins TfR1, 
Fpn, and Cp-GPI. Cytokines IL-6 and IL-1β are expressed at 
much higher levels compared to low-dose LPS/IFN-γ, indicating 
strong inflammatory conditions. Again, bovine lactoferrin damp-
ens these effects, reducing the changes observed in its absence. In 
this case, however, levels of IL-10 significantly increase upon LPS 
stimulation [in line with other reports, e.g., Ref. (28)] and the 
presence of bovine lactoferrin only partially prevents the increase. 
This result suggests that, at variance with stimulation with the 
LPS/IFN-γ mix above, treatment with high doses of LPS triggers 
an endogenous anti-inflammatory response in THP-1 mediated 
by IL-10 and finalized to counteract the massive increase of IL-6 
and IL-1β and of other pro-inflammatory factors.
It is interesting to note that bovine lactoferrin exerts its effect 
both under conditions mimicking the initial stages of infection 
(i.e., treatment with high doses of sole LPS) and when an inflam-
matory outcome has been set up (i.e., treatment with low doses of 
LPS and with IFN-γ). This suggests that, within this experimental 
framework, bovine lactoferrin acts as an anti-inflammatory agent 
able to both prevent the onset of inflammation and to relieve it 
once it has been established.
A last comment deserves to be made regarding the effect of 
inflammatory stimuli on Cp. Cp is well known to be a positive 
acute-phase reactant, i.e., a protein upregulated in the systemic 
response which usually follows a physiological condition that takes 
place in the beginning of an inflammatory process. Thus, Cp levels 
are greatly increased in plasma under inflammatory conditions 
(31, 32). On the other hand, we observe a decrease of the GPI-linked 
isoform in inflamed macrophages. This finding suggests that it is 
possible that the soluble and membrane isoforms of Cp are subject 
to differential regulation, and this could be related to the multifunc-
tional nature of this multicopper oxidase. In plasma, it would play 
a major antioxidant role; therefore, high levels of Cp are required 
to scavenge reactive oxygen species produced in inflammation; 
in specialized cells such as macrophages, the predominant role of 
Cp-GPI would be linked to its ferroxidase activity in combination 
with Fpn to allow efficient iron release from cells to circulation and 
loading onto transferrin, thus avoiding intracellular iron overload 
as well as IDA and AI. Thus, it makes sense that in this latter case, 
bovine lactoferrin in inflamed macrophages restores the synthesis 
for both Cp-GPI and Fpn.
Overall, the capacity of bovine lactoferrin to reduce pro-
inflammatory cytokine production and to prevent the changes 
of the whole set of proteins involved in iron homeostasis, in 
inflamed macrophages, underlines the pivotal role of this natural 
compound in the complex orchestration of iron and inflammatory 
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homeostasis. Several drugs capable of modulating macrophagic 
phenotypes are emerging as attractive molecules for treating 
inflammation, and in this sense, bovine lactoferrin is no exception.
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